Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer.

Tryfonidis K, Papadaki C, Assele S, Lagoudaki E, Menis J, Koutsopoulos A, Trypaki M, Tsakalaki E, Sfakianaki M, Hasan B, Stathopoulos E, Georgoulias V, Souglakos J.

Pharmacogenomics J. 2019 Feb;19(1):15-24. doi: 10.1038/s41397-018-0013-9. Epub 2018 Feb 22.

PMID:
29472587
2.

Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.

Tryfonidis K, Kafousi M, Perraki M, Apostolaki S, Agelaki S, Georgoulias V, Stathopoulos E, Mavroudis D.

Clin Breast Cancer. 2014 Dec;14(6):442-50. doi: 10.1016/j.clbc.2014.04.001. Epub 2014 Jun 2.

PMID:
24958324
3.

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

Katopodis O, Souglakos J, Stathopoulos E, Christopoulou A, Kontopodis E, Kotsakis A, Kalbakis K, Kentepozidis N, Polyzos A, Hatzidaki D, Georgoulias V.

Cancer Chemother Pharmacol. 2014 Aug;74(2):333-40. doi: 10.1007/s00280-014-2509-6. Epub 2014 Jun 15.

PMID:
24930058
4.

BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome.

Saridaki Z, Tzardi M, Sfakianaki M, Papadaki C, Voutsina A, Kalykaki A, Messaritakis I, Mpananis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J.

PLoS One. 2013 Dec 18;8(12):e84604. doi: 10.1371/journal.pone.0084604. eCollection 2013.

5.

Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.

Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E.

Clin Chem. 2014 Jan;60(1):197-205. doi: 10.1373/clinchem.2013.210542. Epub 2013 Oct 16.

6.

A real-time spectral mapper as an emerging diagnostic technology in biomedical sciences.

Epitropou G, Kavvadias V, Iliou D, Stathopoulos E, Balas C.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:1422-5. doi: 10.1109/EMBC.2013.6609777.

PMID:
24109964
7.

Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide.

Karachaliou N, Papadaki C, Lagoudaki E, Trypaki M, Sfakianaki M, Koutsopoulos A, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J.

PLoS One. 2013 Sep 13;8(9):e74611. doi: 10.1371/journal.pone.0074611. eCollection 2013.

8.

Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy.

Vassalou H, Stathopoulos E, Fiolitaki G, Koutsopoulos A, Voutsina A, Georgoulias V, Mavroudis D.

Lung Cancer. 2013 Nov;82(2):324-9. doi: 10.1016/j.lungcan.2013.08.001. Epub 2013 Aug 11.

PMID:
23993732
9.

Probabilities of identifying a micrometastasis in a cervical lymph node from laryngeal cancer. A stereometric approach.

Delides A, Maniadakis M, Stathopoulos E.

Anticancer Res. 2013 Aug;33(8):3213-6.

PMID:
23898081
10.

Preoperative assessment of neurovesical function in children with anorectal malformation: association with vertebral and spinal malformations.

Stathopoulos E, Muehlethaler V, Rais M, Alamo L, Dushi G, Frey P, Ramseyer P, Meyrat BJ.

J Urol. 2012 Sep;188(3):943-7. doi: 10.1016/j.juro.2012.04.117. Epub 2012 Jul 21.

PMID:
22819105
11.

ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer.

Papadaki C, Sfakianaki M, Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J.

J Thorac Oncol. 2012 Apr;7(4):663-71. doi: 10.1097/JTO.0b013e318244bdd4.

12.

Multi-platform data integration in microarray analysis.

Tsiliki G, Zervakis M, Ioannou M, Sanidas E, Stathopoulos E, Potamias G, Tsiknakis M, Kafetzopoulos D.

IEEE Trans Inf Technol Biomed. 2011 Nov;15(6):806-12. doi: 10.1109/TITB.2011.2158232.

PMID:
22113338
13.

Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.

Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, Krüger-Krasagakis S.

Br J Dermatol. 2012 Mar;166(3):491-7. doi: 10.1111/j.1365-2133.2011.10689.x. Epub 2012 Jan 9.

PMID:
21985184
14.

Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma.

Sfiridaki A, Miyakis S, Pappa C, Tsirakis G, Alegakis A, Kotsis V, Stathopoulos E, Alexandrakis M.

J Hematol Oncol. 2011 May 8;4:22. doi: 10.1186/1756-8722-4-22.

15.

Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients.

Saridaki Z, Tzardi M, Papadaki C, Sfakianaki M, Pega F, Kalikaki A, Tsakalaki E, Trypaki M, Messaritakis I, Stathopoulos E, Mavroudis D, Georgoulias V, Souglakos J.

PLoS One. 2011 Jan 20;6(1):e15980. doi: 10.1371/journal.pone.0015980.

16.

Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.

Papadaki C, Tsaroucha E, Kaklamanis L, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J.

Br J Cancer. 2011 Jan 18;104(2):316-23. doi: 10.1038/sj.bjc.6606027. Epub 2010 Dec 14.

17.

Apoptosis and cell proliferation correlated with tumor grade in patients with lung adenocarcinoma.

Kalogeraki A, Tzardi M, Zoras O, Giannikaki E, Papadakis M, Tamiolakis D, Petraki PE, Diamantis A, Siafakas N, Stathopoulos E.

In Vivo. 2010 Sep-Oct;24(5):667-70.

PMID:
20952731
18.

Acute effect of a dual ETA-ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia.

Stathopoulos E, Rolland PH, Héry G, de Magnée C, Paut O, Couchot E, Leprêtre O, Guys JM, de Lagausie P.

Pediatr Surg Int. 2011 Mar;27(3):295-301. doi: 10.1007/s00383-010-2668-4. Epub 2010 Aug 10.

PMID:
20697899
19.

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.

Saridaki Z, Papadatos-Pastos D, Tzardi M, Mavroudis D, Bairaktari E, Arvanity H, Stathopoulos E, Georgoulias V, Souglakos J.

Br J Cancer. 2010 Jun 8;102(12):1762-8. doi: 10.1038/sj.bjc.6605694. Epub 2010 May 18.

20.

Apoptosis and cell proliferation correlated with tumor grade in patients with ampullary carcinoma.

Kalogeraki A, Tzardi M, Papadakis M, Stathopoulos E, Kouroumalis E, Zoras O.

Acta Cytol. 2010 Jan-Feb;54(1):39-42.

PMID:
20306986

Supplemental Content

Loading ...
Support Center